Smith, Jeffrey T.L.,Feldhaus, Andrew L.,Garcia-Martinez, Leon R.
申请号：
AU2017203536
公开号：
AU2017203536A1
申请日:
2017.05.26
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017203536A120170615.pdf#####ABSTRACT The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat mucositis (e.g., oral mucositis) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of mucositis, including oral mucositis.
